Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Researchers discover new mutation hotspot in the human genome

Researchers have discovered new regions of the human genome particularly vulnerable to mutations. These altered stretches of DNA can be passed down to future generations and are important for how we study genetics and disease. The regions are located at the st

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Researchers have discovered new regions of the human genome particularly vulnerable to mutations. These altered stretches of DNA can be passed down to future generations and are important for how we study genetics and disease.

The regions are located at the starting point of genes, also known as transcription start sites. These are sequences where cellular machinery starts to copy DNA into RNA. The first 100 base pairs after a gene's starting point are 35% more prone to mutations compared with what you'd expect by chance, according to the study published today in Nature Communications.

These sequences are extremely prone to mutations and rank among the most functionally important regions in the entire human genome, together with protein-coding sequences." Dr. Donate Weghorn, corresponding author of the study and researcher, Centre for Genomic Regulation, Barcelona

The study found that many of the excess mutations appear immediately after conception, during the first few rounds of cell division in the human embryo. Also known as mosaic mutations, these changes to the DNA sequence end up in some cells but not others and are part of the reason the mutational hotspot has gone undiscovered until now.

A parent can carry disease-contributing mosaic mutations without symptoms because the change ends up in some cells or tissues only. However, they can still pass the mutation on through their eggs or sperm. The child then carries the mutation in all their cells, which could cause disease.

The researchers made the discovery by looking at transcription start sites across 150,000 human genomes from the UK Biobank and 75,000 from the Genome Aggregation Database (gnomAD). They compared the results with data that included information about mosaic mutations from eleven separate family studies.

They found that many gene starting sites across the human genome experienced excess mutations. When the researchers looked more closely, they found the most affected regions were the starting points of sets of genes linked to cancer, brain function and defective limb development.

The mutations are likely to be harmful. The study found a strong excess of mutations near start sites when looking at extremely rare variants, which are normally very recent mutations. That excess shrunk when looking at older, more common variants, suggesting natural selection is filtering the mutations out. In other words, families with mutations in gene starting sites, particularly those linked to cancer and brain function, are less likely to pass them on. Over generations, the mutations do not stick around.

Avoiding false conclusions and finding missed clues

The study can help avoid false conclusions from mutational models. These are tools which help geneticists determine how many mutations are to be expected in specific regions of the genome if nothing special is going on. Clinically, that baseline is used to determine which variants should be paid attention to and which deprioritised.

Knowing that gene starting points are natural mutational hotspots means the true baseline in these regions is higher than previously thought and models need to be recalibrated to take that into account.

"If a model doesn't know this region is naturally mutation-rich, it might expect, say, 10 mutations but observe 50. If the correct baseline is 80, then 50 means fewer than expected and is a sign harmful changes are being removed by natural selection. You would completely miss the importance of that gene," explains Dr. Weghorn.

The study also has implications for genetic studies which only look for mutations present in the child and completely absent in parents. This works well for mutations that are present in every cell, but not for mosaic mutations which end up in a patchwork of different tissues. These studies are filtering out mosaic mutations and inadvertently losing important information about potential contributors to disease.

"There is a blind spot in these studies. To get around this, one could look at the co-occurrence patterns of mutations to help detect the presence of mosaic mutations. Or look at the data again and revisit discarded mutations that occur near the transcription starts of genes most strongly affected by the hotspot," says Dr. Weghorn.

A new source of mutations

The process of transcribing DNA into RNA is hectic. The study explains the mutational hotspot exists because the molecular machinery involved often pauses and restarts near the start line. It can even fire in both directions. At the same time, short-lived structures can form that briefly leave one strand of DNA exposed to possible damage.

All of this, the authors argue, makes transcription start sites more prone to mutations during the rapid cell divisions that follow conception. Cells can usually repair these alterations, but under the pressure of needing to grow fast, cells leave some mutations unpatched like scars on the human genome.

The discovery adds a previously missing piece on how mutations arise in the first place. The obvious culprits, like errors during DNA replication or damage from ultraviolet rays, have been known about for decades. "Finding a new source of mutations, particularly those affecting the human germline, doesn't happen often," concludes Dr. Weghorn.

Cortés Guzmán, M., et al. (2025). Transcription start sites experience a high influx of heritable variants fueled by early development. Nature Communications. doi: 10.1038/s41467-025-66201-0. https://www.nature.com/articles/s41467-025-66201-0

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What's next?

Stupp's team is currently testing these systems in animal studies and adding additional signals to create highly bioactive therapies. "With the success of the study in human cartilage cells, we predict that cartilage regeneration will be greatly enhanced when used in highly translational pre-clinical models," Stupp said. "It should develop into a novel bioactive material for regeneration of cartilage tissue in joints." Stupp's lab is also testing the ability of dancing molecules to regenerate bone - and already has promising early results, which likely will be published later this year. Simultaneously, he is testing the molecules in human organoids to accelerate the process of discovering and optimizing therapeutic materials. Stupp's team also continues to build its case to the Food and Drug Administration, aiming to gain approval for clinical trials to test the therapy for spinal cord repair. "We are beginning to see the tremendous breadth of conditions that this fundamental discovery on 'dancing molecules' could apply to," Stupp said. "Controlling supramolecular motion through chemical design appears to be a powerful tool to increase efficacy for a range of regenerative therapies." The study, "Supramolecular motion enables chondrogenic bioactivity of a cyclic peptide mimetic of transforming growth factor-β1," was supported by a gift from Mike and Mary Sue Shannon to Northwestern University for research on musculoskeletal regeneration at the Center for Regenerative Nanomedicine of the Simpson Querrey Institute for BioNanotechnology. Yuan, S. C., et al. (2024). Supramolecular Motion Enables Chondrogenic Bioactivity of a Cyclic Peptide Mimetic of Transforming Growth Factor-β1. Journal of the American Chemical Society. doi.org/10.1021/jacs.4c05170

Source: www.news-medical.net ↗
02Taking both of the topics that we have discussed into consideration, where would you like your research to lead into the future?

As in the past, I hope the new technologies and new knowledge will be useful in the future. It is also important because, in doing my research, the next generation of scientists are educated and can continue such work long after I am gone. That is how science advances, often dragging humanity up and along with it.

Source: www.news-medical.net ↗
03What are the Applications of Affimers?

Affimers can be combined with traditional biological tests to increase our understanding of proteins. For example, affimers have been used in affinity assays, among others. They have also been used in biosensors and in cell cultures to manipulate cell signaling. Affimers have been successfully applied both in vitro and in vivo. Some of the applications that have been tested using affimers include cell imaging, super resolution microscopy, protein function modulation, magnetic nanoparticle formation, and MRI reagent development. Affimers with enhanced specificity for tubulin have been used in super resolution microscopy with high success, and can target regions of the tubulin structure that antibodies are typically restricted from. It is likely that more applications will be discovered in the future as the use of affimers becomes more widespread. For example, thanks to growing libraries of affimers, it has been possible to create affinity microarrays to discover biomarkers and potential pharmaceuticals. By finding biomarkers, affimers have been applied to cancer studies, where they have been used to target a protein in tumor vessel formation called the VEGF receptor.

Source: www.news-medical.net ↗
04What are Introns?

Introns are nucleotide sequences in DNA and RNA that do not directly code for proteins, and are removed during the precursor messenger RNA (pre-mRNA) stage of maturation of mRNA by RNA splicing. Introns can range in size from 10’s of base pairs to 1000’s of base pairs, and can be found in a wide variety of genes that generate RNA in most living organisms, including viruses. Four distinct types of introns have been identified:

Source: www.news-medical.net ↗
05Collaboration has played a significant role in your research career. Can you highlight some of the most impactful collaborations you've had and how they have contributed to your research in axon biology?

A significant collaboration is with the Versus Arthritis Pain Center in Nottingham, in particular with Vicky Chapman and Gareth Hathway. Initially, my work wasn't focused on pain research, but joining forces with experts from this center led half of my lab's work to be directed towards pain-related projects. Another meaningful collaboration involves studying motor neuron diseases alongside Prof. Rob Layfield and Dr. Dan Scott. This collaboration allows us to leverage our expertise in RNA and neuron development and apply it to conditions like motor neuron disease.

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →